| 541 |
Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders |
قسم الصيدلة الصناعية |
2020 |
| 542 |
Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders |
قسم الصيدلة الصناعية |
2020 |
| 543 |
Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids |
قسم الكيمياء العضوية الصيدلية |
2020 |
| 544 |
Cytotoxic Activity of Abietane-Type Diterpenes Isolated From Taxodium distichum Against Cancer Cells Adapted to Nutrient-Starved Conditions |
قسم العقاقير |
2020 |
| 545 |
Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation |
قسم الكيمياء العضوية الصيدلية |
2020 |
| 546 |
Design and synthesis of new pyranoquinolinone heteroannulated to triazolopyrimidine of potential apoptotic antiproliferative activity |
قسم الكيمياء العضوية الصيدلية |
2020 |
| 547 |
Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors |
قسم الكيمياء العضوية الصيدلية |
2020 |
| 548 |
Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors |
قسم الكيمياء العضوية الصيدلية |
2020 |
| 549 |
Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors |
قسم الكيمياء العضوية الصيدلية |
2020 |
| 550 |
Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors |
قسم الكيمياء العضوية الصيدلية |
2020 |
